M/19/017 – Duke Street (DS Spring)/ DCC Vital (UK) & Kent Pharma UK
The proposed acquisition by Duke Street, via DS Spring Bidco Limited of sole control of each of DCC Vital (UK) Limited and Kent Pharma UK Limited has been cleared by the Competition and Consumer Protection Commission.
|Notification date||Decision date|
|Tuesday June 25, 2019||Friday, August 2, 2019|
|Parties Involved||Business activities|
|Duke Street LLP||
The acquirer, DS Spring Bidco Limited, is a portfolio company ultimately controlled by Duke Street LLP. Duke Street LLP is a private equity firm specialising in investing in mature, mid-market western European businesses. Duke Street LLP focuses on four primary sector markets, Consumer, Healthcare, Industrials and and Engineering, and Services.
|Kent Pharma UK Limited||
Kent Pharma UK Limited is involved in the manufacture, supply and service of generic medicines across hospitals and primary and secondary care sectors. It is currently owned and controlled by Fannin (UK) Limited, and is ultimately owned and controlled by DCC plc.
|DCC Vital (UK) Limited||
DCC Vital (UK) Limited sells and distributes a broad range of own and third party pharmaceutical products to healthcare providers across the UK and Ireland. DCC Vital (UK) Limited is owned and controlled by DCC Vital Ireland Limited. All of these entities are ultimately owned and controlled by DCC plc.
|Economic sector||Media merger|
|Submissions from third parties due by:|
|Phase 1||Phase 2|
|Monday, July 8, 2019|
|Current status: Completed|
|Cleared (Phase 1)|
|Authorised Officer Assigned||Contact Details|
Telephone: 00 353 1 4703662
Media enquiries: email@example.com